memo - Magazine of European Medical Oncology

ESMO 2021

Rupert Bartsch

New targeted therapies/small molecules in oncology and hematology

Anna Sophie Berghoff

COVID-19 crisis and cancer

Rupert Bartsch, Wolfgang Hilbe

COVID-19: New disease mechanism is simultaneously a therapeutic target

Clemens A. Schmitt

Renal cell carcinoma—presentation highlights from the ESMO Congress 2021

Georg C. Hutterer, Martin Pichler

Highlights ESMO 2021—lung cancer

Markus Rauter

ESMO 2021—my top three abstracts in breast cancer

Christoph Suppan

ESMO 2021—highlights in colorectal cancer

Lukas Weiss

Breast Cancer—Essential news of current guidelines

Kathrin Strasser-Weippl

Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022

Jan-Paul Bohn

Antibody–drug conjugates—the magic bullet?

Marie-Bernadette Aretin

Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer

Maximilian Marhold

New targeted therapies in kidney cancer

Karl Mayrhofer, Dora Niedersüß-Beke

Tracking mutation and drug-driven alterations of oncokinase conformations

Andreas Feichtner, Valentina Kugler, Selina Schwaighofer, Thomas Nuener, Jakob Fleischmann, Eduard Stefan

Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report

Ahmed H. Al Sharie, Yazan O. Al Zu’bi, Sarah Al Sharie, Hawra A. Baydoun, Farah H. Atawneh, Osama Alshari, Dima Albals

Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report

Maher Salamoon, Mazen Kenj

High mortality in patients with active malignancy and severe COVID-19

Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür

Cardiopulmonary sequelae of COVID-19

Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature

Simon Udovica, Kathrin Strasser-Weippl, Eva Fischer, Dora Niedersüß-Beke

Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab

Beatrix Mutschlechner, Susanne Dertinger, Felix Offner, Veronika Buck, Alexander Becherer, Klaus Gasser, Bernd Hartmann, Thomas Winder